Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06776913 · ClinicalTrials.gov registry record · NA
Randomized Controlled Trial Comparing Adult to Pediatric Colonoscope in Obese Patients.
A NA study, sponsored by Cleveland Clinic Florida.
- Completed
- Registry status
- NA
- Development phase
- 244
- Enrollment target
NCT06776913: Completed NA study, sponsored by Cleveland Clinic Florida.
NCT06776913 is a NA study that has completed, run by Cleveland Clinic Florida. The registered enrollment target is 244 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06776913, a NA study, has completed, sponsored by Cleveland Clinic Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 244 participants
- Enrollment target
Study Summary
The goal of this study is to test which colonoscope works best in people who are above a certain body mass index. Currently, both pediatric and adult colonoscopes are accepted as standard treatments in colonoscopies. Endoscopist pick which one to use based on personal preference and what is available.
Primary Outcome
The outcome aims to measure the difficult colonoscope which is defined as either not reaching the cecum, needing more than 10 minutes, or the need to exchange to a different device.
Interventions
- DEVICE Colonoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2025-01-06 |
| Est. Completion | 2025-09-24 |
| Phase | NA |
What the finished NCT06776913 record still lists
NCT06776913 is an interventional study that assigns participants to a tested intervention. The registered 244 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Colonoscopy is the first listed.
NCT06776913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06776913 about?
NCT06776913 is a clinical study titled "Randomized Controlled Trial Comparing Adult to Pediatric Colonoscope in Obese Patients.". The goal of this study is to test which colonoscope works best in people who are above a certain body mass index. Currently, both pediatric and adult colonoscopes are accepted as standard treatments in colonoscopies. Endoscopist pick which one to use based on personal preference and what is availabl...
What is the current status of trial NCT06776913?
This trial is currently completed. It is a NA study. The enrollment target is 244 participants. The study started on 2025-01-06. Estimated completion is 2025-09-24.
What interventions are being tested in trial NCT06776913?
The interventions under investigation include: Colonoscopy (DEVICE).
Who is sponsoring clinical trial NCT06776913?
This trial is sponsored by Cleveland Clinic Florida, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06776913's enrollment target sits among peer trials
244 438th of 2000 higher than 1,563 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02227251 · 244 participants · Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT04317534 · 244 participants · Phase 2
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
- NCT04683250 · 244 participants · Phase 1
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- NCT04686305 · 244 participants · Phase 1
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI